Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 44kWORD 10k
7 April 2021
E-001880/2021
Question for written answer  E-001880/2021
to the Commission
Rule 138
Annika Bruna (ID), Hélène Laporte (ID), Julie Lechanteux (ID), Herve Juvin (ID)
 Subject: New plant-breeding techniques

Cultivating genetically modified organisms (GMOs) for commercial purposes has been banned in France since 2008. However, new plant-breeding techniques (NBTs) are making it possible to change plant DNA without inserting foreign genes, by using techniques such as CRISPR-Cas9.

Although the modifications produced using these new techniques are no different from those that occur naturally, the time savings by comparison with conventional plant breeding methods can be measured in years.

However, the Joint Advisory Ethics Committee of the French National Research Institute for Agriculture, Food and Environment (INRAE), the French Agricultural Research Centre for International Development (CIRAD) and the French Research Institute for Exploitation of the Sea (IFREMER) consider that these NBTs pose the same risks as GMOs, particularly as regards agro-biodiversity(1). They can also lead to undesirable gene mutations, which may later cause unforeseen and not immediately detectable health problems.

The Court of Justice of the European Union therefore considers that these NBTs are subject to Directive 2001/18/EC and must be treated as GMOs(2). Since this judgment was handed down, however, the French Government has been slow to issue a decree defining the legal status of these NBTs at national level.

Does the Commission have any information on the progress France has made in drawing up its NBT rules?

Supporter(3)

(1)https://www.inrae.fr/actualites/analyser-questions-ethiques-politiques-posees-ledition-du-genome-vegetaux
(2)http://curia.europa.eu/juris/document/document.jsf;jsessionid=9ea7d2dc30ddfa7a9c6cfd4146e0ae02b 742b358ad6d.e34KaxiLc3qMb40Rch0SaxyOahf0?text=&docid=204387&pageIndex=0&doclang=FR& mode=req&dir=&occ=first&part=1&cid=740278
(3)This question is supported by a Member other than the authors: Jean-Paul Garraud (ID)
Original language of question: FR
Last updated: 26 April 2021Legal notice - Privacy policy